Guest editorial

Highlight report: Import of fatty acids by metastasizing tumor cells

Tim Brecklinghaus1[*]

1Leibniz Research Centre for Working Environment and Human Factors at the Technical University of Dortmund (IfADo), 44139, Dortmund, Germany

EXCLI J 2018;17:Doc1154

 



Recently Pascual and colleagues have contributed a study about the identity of cells that initiate metastasis (Pascual et al., 2017[22]). They identified a cell type in human oral carcinomas with the following properties: (1) slow-cycling, (2) CD44-bright, (3) low expression of mesenchymal genes, (4) ability to initiate metastasis in mouse models and (5) high expression of the fatty acid receptor CD36. CD36 is a membrane protein on the surface of many mammalian cells that imports fatty acids (Yang et al., 2018[34]; Umbarawan et al., 2018[31]; Son et al., 2018[28]). CD36 has been shown to be critical for supply with fatty acids and for maintenance of energy metabolism under numerous conditions (Wen et al, 2017[33]; Chen et al, 2016[5]; Nakatani et al., 2015[21]; le Foll et al., 2015[15], 2013[14]). In their recent study Pascual et al. report that neutralizing antibodies against CD36 reduce the formation of metastasis in orthotopic mouse models of oral cancer (Pascual et al., 2017[22]). A further finding of this study is that NOD scid gamma mice developed larger lymph node metastases in a CD36 dependent manner, when the mice received a high-fat diet. Moreover, the authors report that CD36 positive cells are metastasis initiating and are characterized by a lipid metabolism signature (Pascual et al., 2017[22]). Based on publicly available data, high expression of CD36 was associated with poor disease-free survival in breast, lung and urinary bladder cancer (Pascual et al., 2017[22]).

In the past decade much progress has been made in understanding the principles that control formation of metastases (McGranahan et al, 2017[20]; Lambert et al., 2017[13]; Adawy, 2017[1]; Marchan, 2012[18]; Cadenas, 2012[2]; Mantovani et al., 2017[17]; Zhan et al, 2017[35]). It is generally accepted that the cellular and humoral immune system play an important role in preventing metastasis (Schmidt et al., 2018[25], 2012[24], 2008[23]; Godoy et al., 2014[6]; Heimes et a., 2017[8][9]; Sicking et al., 2014[26]).

In many tumor types high expression of proliferation associated genes has been shown to lead to an increased risk of metastasis (Schmidt et al., 2008[23]; Siggelkow et al., 2012[27]; Jabs et al., 2017[11]; Wei et al,, 2017[32]; Knaack, et al, 2018[12]). Moreover, high expression of antioxidative factors (Cadenas et al, 2010[3]), disturbed expression of genes involved in the control of circadian rhythm (Cadenas et al., 2014[4]) and actin binding proteins (Stock et al., 2015[30]) are associated with shorter metastasis-free interval.Different principles have been shown to control breast cancer metastasis that occurs within the first three years after the primary tumor or later (Hellwig et al., 2016[10]; Hammad et al., 2016[7]). Finally, factors involved in glycerophospholipid metabolism have been shown to influence the capacity of tumor cells to migrate, attach to surfaces and to metastasize (Stewart et al., 2012[29]; Lesjak et al., 2014[16]; Marchan et al., 2017[19]).

In conclusion, Pascual and colleagues bring forward an interesting concept that metastasis-initiating tumor cells rely on dietary lipids in a CD36 dependent manner. It remains to be shown, whether CD36 is a promising target for anti-cancer therapy.

 

References

1. Adawy A. Highlight report: Limits of prognostication of non-small cell lung cancer. EXCLI J. 2017;16:808-9.
2. Cadenas C. Prognostic signatures of breast cancer: Perou's molec-ular subtypes and Schmidt's metagenes. EXCLI J. 2012;11:204-7.
3. Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, et al. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res. 2010;12(3):R44.
4. Cadenas C, van de Sandt L, Edlund K, Lohr M, Hellwig B, Marchan R, et al. Loss of circadian clock gene expression is associated with tumor progression in breast cancer. Cell Cycle. 2014;13:3282-91.
5. Chen YP, Tsai CW, Shen CY, Day CH, Yeh YL, Chen RJ, et al. Palmitic acid interferes with energy metabolism balance by adversely switching the SIRT1-CD36-fatty acid pathway to the PKC zeta-GLUT4-glucose pathway in cardiomyoblasts. J Nutr Biochem. 2016;31:137-49.
6. Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, et al. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 2014;21:491-9.
7. Hammad S, Osman GS, Ezzeldien M, Ahmed H, Kotb AM. Highlight report: Predicting late metastasis in breast cancer. EXCLI J. 2016;15:867-9.
8. Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Elger T, et al. Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer. Breast Cancer Res Treat. 2017;165:293-300.
9. Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Gebhard S, et al. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer. J Cancer Res Clin Oncol. 2017;143:1123-31.
10. Hellwig B, Madjar K, Edlund K, Marchan R, Cadenas C, Heimes AS, et al. Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy. PLoS One. 2016;11(12):e0167585.
11. Jabs V, Edlund K, König H, Grinberg M, Madjar K, Rahnenführer J, et al. Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer. PLoS One. 2017;12 (11):e0187246.
12. Knaack H, Lenk L, Philipp LM, Miarka L, Rahn S, Viol F, et al. Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells. Oncotarget. 2018;9:31771-86.
13. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670-91.
14. Le Foll C, Dunn-Meynell A, Musatov S, Magnan C, Levin BE. FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice. Diabetes. 2013;62:2709-16.
15. Le Foll C, Dunn-Meynell AA, Levin BE. Role of FAT/CD36 in fatty acid sensing, energy, and glucose homeostasis regulation in DIO and DR rats. Am J Physiol Regul Integr Comp Physiol. 2015;308:R188-98.
16. Lesjak MS, Marchan R, Stewart JD, Rempel E, Rahnenführer J, Hengstler JG. EDI3 links choline metabolism to integrin expression, cell adhesion and spreading. Cell Adh Migr. 2014;8:499-508.
17. Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399-416.
18. Marchan R. Lung and breast cancer research: immunoglobulin Kappa C hits the headlines. EXCLI J. 2012;11:237-9.
19. Marchan R, Büttner B, Lambert J, Edlund K, Glaeser I, Blaszkewicz M, et al. Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma. Cancer Res. 2017;77:4589-601.
20. McGranahan T, Li G, Nagpal S. History and current state of immunotherapy in glioma and brain metastasis. Ther Adv Med Oncol. 2017;9:347-68.
21. Nakatani K, Watabe T, Masuda D, Imaizumi M, Shimosegawa E, Kobayashi T, et al. Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice. Metabolism. 2015;64:1165-74.
22. Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41-5.
23. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68:5405-13.
24. Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, et al. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res. 2012;18:2695-703.
25. Schmidt M, Weyer-Elberich V, Hengstler JG, Heimes AS, Almstedt K, Gerhold-Ay A et al. Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population. Breast Cancer Res. 2018;20(1):15.
26. Sicking I, Rommens K, Battista MJ, Böhm D, Gebhard S, Lebrecht A, et al. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients. BMC Cancer. 2014;14:952.
27. Siggelkow W, Boehm D, Gebhard S, Battista M, Sicking I, Lebrecht A, et al. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients. BMC Cancer. 2012;12:562.
28. Son NH, Basu D, Samovski D, Pietka TA, Peche VS, Willecke F, et al. Endothelial cell CD36 optimizes tissue fatty acid uptake. J Clin Invest. 2018;128:4329-42.
29. Stewart JD, Marchan R, Lesjak MS, Lambert J, Hergenroeder R, Ellis JK, et al. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis. Proc Natl Acad Sci U S A. 2012;109:8155-60.
30. Stock AM, Klee F, Edlund K, Grinberg M, Hammad S, Marchan R, et al. Gelsolin is associated with longer metastasis-free survival and reduced cell migration in estrogen receptor-positive breast cancer. Anticancer Res. 2015;35:5277-85.
31. Umbarawan Y, Syamsunarno MRAA, Koitabashi N, Obinata H, Yamaguchi A, Hanaoka H, et al. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure. Sci Rep. 2018;8(1):12035.
32. Wei Y, Dong J, Li F, Wei Z, Tian Y. Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer. EXCLI J. 2017;16:1165-76.
33. Wen SY, Velmurugan BK, Day CH, Shen CY, Chun LC, Tsai YC, et al. High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte. J Cell Physiol. 2017;232:3020-9.
34. Yang P, Su C, Luo X, Zeng H, Zhao L, Wei L, et al. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway. Cancer Lett. 2018;438:76-85.
35. Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461-73.
 
 
 

[*] Corresponding Author:

Tim Brecklinghaus, Leibniz Research Centre for Working Environment and Human Factors at the Technical University of Dortmund (IfADo), 44139, Dortmund, Germany, eMail: brecklinghaus@ifado.de